Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2002 Nov;57(11):967–972. doi: 10.1136/thorax.57.11.967

Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study

N Godtfredsen 1, J Vestbo 1, M Osler 1, E Prescott 1
PMCID: PMC1746230  PMID: 12403880

Abstract

Background: Little is known about the effects of changes in smoking habits on the subsequent risk of chronic obstructive pulmonary disease (COPD). The aim of this study was to investigate the relationship between smoking cessation and reduction and admission to hospital for COPD in a general population sample.

Methods: A total of 19 709 participants from three prospective population studies in Copenhagen were followed with record linkage for date of first hospital admission for COPD until 1998 (mean follow up 14 years). Heavy smokers (≥15 cigarettes/day) who reduced their tobacco consumption by at least 50% between the two initial examinations without quitting and smokers who stopped smoking during this time were compared with continuous heavy smokers using a Cox proportional hazards model.

Results: During the follow up period 1260 subjects (741 men and 519 women) were admitted to hospital for COPD. After multivariate adjustment, quitting smoking was associated with a significant reduction in the risk of hospital admission. The relative hazard (HR) was 0.57 (95% confidence interval (CI) 0.33 to 0.99). Those who reduced smoking did not show a significantly lower risk of hospitalisation than continuing heavy smokers (HR 0.93 (95% CI 0.73 to1.18)). Exclusion of events during the first 5 study years, detailed adjustment for lung function, or restriction of analyses to participants with impaired pulmonary function did not reverse the observed trend.

Conclusions: Self-reported smoking cessation is associated with a reduction in the risk of COPD morbidity of approximately 40%; the benefit of smoking reduction is questionable.

Full Text

The Full Text of this article is available as a PDF (170.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthonisen N. R., Connett J. E., Kiley J. P., Altose M. D., Bailey W. C., Buist A. S., Conway W. A., Jr, Enright P. L., Kanner R. E., O'Hara P. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994 Nov 16;272(19):1497–1505. [PubMed] [Google Scholar]
  2. Benowitz N. L., Jacob P., 3rd, Kozlowski L. T., Yu L. Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med. 1986 Nov 20;315(21):1310–1313. doi: 10.1056/NEJM198611203152102. [DOI] [PubMed] [Google Scholar]
  3. Bolliger C. T., Zellweger J. P., Danielsson T., van Biljon X., Robidou A., Westin A., Perruchoud A. P., Säwe U. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ. 2000 Aug 5;321(7257):329–333. doi: 10.1136/bmj.321.7257.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Doll R., Peto R., Wheatley K., Gray R., Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ. 1994 Oct 8;309(6959):901–911. doi: 10.1136/bmj.309.6959.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fagerström K. O., Tejding R., Westin A., Lunell E. Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker? Tob Control. 1997 Winter;6(4):311–316. doi: 10.1136/tc.6.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Godtfredsen N. S., Prescott E., Osler M., Vestbo J. Predictors of smoking reduction and cessation in a cohort of danish moderate and heavy smokers. Prev Med. 2001 Jul;33(1):46–52. doi: 10.1006/pmed.2001.0852. [DOI] [PubMed] [Google Scholar]
  7. Hagerup L., Eriksen M., Schroll M., Hollnagel H., Agner E., Larsen S. The Glostrup population studies. Collection of epidemiologic tables. Reference values for use in cardiovascular population studies. Scand J Soc Med Suppl. 1981;20:1–112. [PubMed] [Google Scholar]
  8. Hein H. O., Suadicani P., Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up in the Copenhagen male study. BMJ. 1996 Mar 23;312(7033):736–741. doi: 10.1136/bmj.312.7033.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hughes J. R., Cummings K. M., Hyland A. Ability of smokers to reduce their smoking and its association with future smoking cessation. Addiction. 1999 Jan;94(1):109–114. doi: 10.1046/j.1360-0443.1999.9411097.x. [DOI] [PubMed] [Google Scholar]
  10. Hughes J. R. Reduced smoking: an introduction and review of the evidence. Addiction. 2000 Jan;95 (Suppl 1):S3–S7. doi: 10.1080/09652140032008. [DOI] [PubMed] [Google Scholar]
  11. Hurt R. D., Croghan G. A., Wolter T. D., Croghan I. T., Offord K. P., Williams G. M., Djordjevic M. V., Richie J. P., Jr, Jeffrey A. M. Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine Tob Res. 2000 Nov;2(4):327–336. doi: 10.1080/713688154. [DOI] [PubMed] [Google Scholar]
  12. Lange P., Groth S., Nyboe G. J., Mortensen J., Appleyard M., Jensen G., Schnohr P. Effects of smoking and changes in smoking habits on the decline of FEV1. Eur Respir J. 1989 Oct;2(9):811–816. [PubMed] [Google Scholar]
  13. Mendez D., Warner K. E., Courant P. N. Has smoking cessation ceased? Expected trends in the prevalence of smoking in the United States. Am J Epidemiol. 1998 Aug 1;148(3):249–258. doi: 10.1093/oxfordjournals.aje.a009632. [DOI] [PubMed] [Google Scholar]
  14. Murray R. P., Anthonisen N. R., Connett J. E., Wise R. A., Lindgren P. G., Greene P. G., Nides M. A. Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group. J Clin Epidemiol. 1998 Dec;51(12):1317–1326. doi: 10.1016/s0895-4356(98)00120-6. [DOI] [PubMed] [Google Scholar]
  15. Pauwels R. A., Buist A. S., Calverley P. M., Jenkins C. R., Hurd S. S., GOLD Scientific Committee Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001 Apr;163(5):1256–1276. doi: 10.1164/ajrccm.163.5.2101039. [DOI] [PubMed] [Google Scholar]
  16. Pelkonen M., Notkola I. L., Tukiainen H., Tervahauta M., Tuomilehto J., Nissinen A. Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax. 2001 Sep;56(9):703–707. doi: 10.1136/thorax.56.9.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pelkonen M., Tukiainen H., Tervahauta M., Notkola I. L., Kivelä S. L., Salorinne Y., Nissinen A. Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men. Thorax. 2000 Sep;55(9):746–750. doi: 10.1136/thorax.55.9.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Prescott E., Bjerg A. M., Andersen P. K., Lange P., Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997 Apr;10(4):822–827. [PubMed] [Google Scholar]
  19. Rennard S. I., Daughton D., Fujita J., Oehlerking M. B., Dobson J. R., Stahl M. G., Robbins R. A., Thompson A. B. Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers. Eur Respir J. 1990 Jul;3(7):752–759. [PubMed] [Google Scholar]
  20. Scanlon P. D., Connett J. E., Waller L. A., Altose M. D., Bailey W. C., Buist A. S., Tashkin D. P., Lung Health Study Research Group Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):381–390. doi: 10.1164/ajrccm.161.2.9901044. [DOI] [PubMed] [Google Scholar]
  21. Seemungal T. A., Donaldson G. C., Bhowmik A., Jeffries D. J., Wedzicha J. A. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000 May;161(5):1608–1613. doi: 10.1164/ajrccm.161.5.9908022. [DOI] [PubMed] [Google Scholar]
  22. Sherrill D. L., Holberg C. J., Enright P. L., Lebowitz M. D., Burrows B. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):591–597. doi: 10.1164/ajrccm.149.3.8118623. [DOI] [PubMed] [Google Scholar]
  23. Strassels S. A., Smith D. H., Sullivan S. D., Mahajan P. S. The costs of treating COPD in the United States. Chest. 2001 Feb;119(2):344–352. doi: 10.1378/chest.119.2.344. [DOI] [PubMed] [Google Scholar]
  24. Stratton K., Shetty P., Wallace R., Bondurant S. Clearing the smoke: the science base for tobacco harm reduction--executive summary. Tob Control. 2001 Jun;10(2):189–195. doi: 10.1136/tc.10.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Vestbo J., Prescott E., Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996 May;153(5):1530–1535. doi: 10.1164/ajrccm.153.5.8630597. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES